Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
54.1%
% of BHCHX's 40 holdings also in FMED
34.5%
% of FMED's 65 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORPORATION | 5.3% | 5.6% | 5.3% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 4.7% | 4.7% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 3.8% | 3.8% |
 |
ARGENX SE ADR | 4.1% | 2.9% | 2.9% |
|
STRYKER CORPORATION | 3.2% | 2.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to FMED
|
ELI LILLY & CO | 7.0% |
|
ELI LILLY AND COMPANY | 7.0% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 3.5% |
 |
ICON PLC | 3.2% |
|
ELEVANCE HEALTH, INC. | 2.7% |
|
MCKESSON CORPORATION | 2.7% |
|
UNITEDHEALTH GROUP INC | 2.6% |
|
UNITEDHEALTH GROUP INCORPORATED | 2.6% |
|
THE COOPER COMPANIES, INC. | 2.6% |
BHCHX Underweight Relative to FMED
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
|
REGENERON PHARMACEUTICALS | -3.8% |
|
INSULET CORP | -3.4% |
|
EXACT SCIENCES CORP | -2.6% |
|
UCB SA | -2.3% |
|
PENUMBRA, INC. | -2.1% |
|
ROYALTY PHARMA PLC CLASS A | -2.1% |
|
DANAHER CORPORATION | -2.0% |
|
DANAHER CORP | -2.0% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.0% |